Abstract
Abstract Artificial intelligence (AI) can be trained to recognize a hallmark of invasive lobular carcinoma—inactivation of the CDH1 gene—and identify tumor features that may be missed with genomic sequencing. In the future, AI could help identify new targets for treatment in invasive lobular carcinoma and other malignancies.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
